This course will provide an overview on Peritoneal Dialysis (PD) to Home Hemodialysis (HHD) transition pathways, potential reasons for PD technique failure, patient considerations on choosing HHD. It will highlight the importance of early modality education and the outcomes with a PD to HHD approach.
*This is currently available as non-CE course only.
This course will provide an overview on the current state of home therapies. It will describe why home dialysis therapies are underutilized and list reasons to justify the use of home therapies as a first-line option. It will also explain important patient and caregiver factors to consider when choosing between peritoneal dialysis and home hemodialysis.
This course discusses the pathophysiology of Mineral Bone Disorder in chronic kidney disease (CKD) and reviews the roles of the major players in mineral bone homeostasis. The course also provides an introduction to the management and treatment approaches for this disorder.
KDIGO CKD-MBD 2017 Updates is available now! Click Here to start presentation.
Learn about the 2017 Updates of the KDOQI Mineral and Bone Disorder Guidelines and stay up-to-date with topics related to MBD diagnosis, recommended phosphorus intake, goal phosphorus levels, goal PTH levels, and MBD in transplant patients. The key differences between the 2017 and 2009 guideline recommendations are highlighted in the short presentation. Full guideline document can be accessed at the end of the presentation or by clicking on the references icon.
This course will review renal anatomy and nephron structure, principles of renal physiology, Acute Kidney Injury (AKI) prevalence and classification, Chronic Kidney Disease (CKD) prevalence and classification.
This course will describe fluid compartments of the body and the role of the kidneys in fluid management, the consequences of fluid overload in kidney disease, guideline recommendations on fluid management approaches and the principles and applications of tools for measuring and evaluating fluid overload in patients with kidney disease.
This course discusses the clinical manifestations, diagnostic criteria, etiologies and guideline recommendations on the management of anemia in Chronic Kidney Disease (CKD). It provides an overview on iron deficiency anemia, Erythropoietin Stimulating Agents (ESAs) recommendations and the use of IV vs. oral iron agents.
This module discusses the definition of mineral bone disorder (MBD) in chronic kidney disease (CKD), important markers in CKD-MBD and monitoring parameters.
This module provides an overview on pathophysiology of CKD-MBD and review the roles of different key players in mineral bone homeostasis.
This module provides an introduction to the management and treatment approaches for CKD-MBD.